Silverarc Capital Management, LLC Eloxx Pharmaceuticals, Inc. Transaction History

Silverarc Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$0.15 - $7.2 $8,545 - $410,184	56,970 Added 5.47%	1,098,469 $187,000
Q2 2022 Jul 25, 2022	SELL	$0.24 - $0.58 $218,268 - $527,481	-909,450 Reduced 46.62%	1,041,499 $281,000
Q1 2022 May 13, 2022	BUY	$0.4 - $0.72 $8,342 - $15,017	20,857 Added 1.08%	1,950,949 $1.09 Million
Q4 2021 Feb 14, 2022	BUY	$0.62 - $1.61 $415,556 - $1.08 Million	670,252 Added 53.2%	1,930,092 $1.36 Million
Q3 2021 Nov 15, 2021	SELL	$1.22 - $2.0 $765,792 - $1.26 Million	-627,699 Reduced 33.25%	1,259,840 $2.05 Million
Q2 2021 Aug 16, 2021	BUY	$1.35 - $3.36 $2.55 Million - $6.34 Million	1,887,539 New	1,887,539 $3.76 Million

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.